InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

Current share price for GSS : $0.080 0.007 (8.05%)+

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Ceasing to be a substantial holder 27 Aug 2026 4:24PM $0.087 $0.080 fallen by 8.05%
$18 Genetic Signatures and Microba in Merger Discussions 26 Aug 2026 9:30AM $0.080 $0.080 fallen by 0%
$18 Change in Substantial Shareholder Notice from BDX 26 Aug 2026 8:35AM $0.080 $0.080 fallen by 0%
$18 Change in substantial holding 25 Aug 2026 2:12PM $0.076 $0.080 risen by 5.26%
$18 FY26 Appendix 4G and Corporate Governance Statement 25 Aug 2026 9:29AM $0.073 $0.080 risen by 9.59%
$18 FY26 Market Update 25 Aug 2026 9:25AM $0.073 $0.080 risen by 9.59%
$18 FY26 Results Release 25 Aug 2026 9:15AM $0.073 $0.080 risen by 9.59%
$18 FY26 Appendix 4E and Annual Report 25 Aug 2026 9:09AM $0.073 $0.080 risen by 9.59%
$18 FY 26 Annual Results and Investor Webinar Notification 24 Aug 2026 10:16AM $0.067 $0.080 risen by 19.40%
$18 Commercial Testing Commences at Hvidovre Hospital in Denmark 21 Aug 2026 9:26AM $0.063 $0.080 risen by 26.98%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jul 2026 2:11PM $0.059 $0.080 risen by 35.59%
$18 Becoming a substantial holder from BDX 2 Jul 2026 5:13PM $0.065 $0.080 risen by 23.08%
$18 GSS responds to the BCAL Diagnostics Announcement 2 Jul 2026 2:41PM $0.066 $0.080 risen by 21.21%
$18 BDX: BCAL to Acquire Shares in Genetic Signatures 2 Jul 2026 10:04AM $0.068 $0.080 risen by 17.65%
$18 Ceasing to be a substantial holder 1 Jul 2026 12:20PM $0.067 $0.080 risen by 19.40%
$18 Change of Company Secretary 19 Jun 2026 8:58AM $0.067 $0.080 risen by 19.40%
$18 Change in substantial holding 18 Jun 2026 4:55PM $0.067 $0.080 risen by 19.40%
$18 Change in substantial holding 16 Jun 2026 11:24AM $0.064 $0.080 risen by 25%
$18 Investor Presentation 10 Jun 2026 8:24AM $0.071 $0.080 risen by 12.68%
$18 Investor Webinar Notification 9 Jun 2026 8:29AM $0.078 $0.080 risen by 2.56%
$18 Final Director's Interest Notice 8 May 2026 8:17AM $0.080 $0.080 fallen by 0%
$18 Board Reorganisation 8 May 2026 8:17AM $0.080 $0.080 fallen by 0%
$18 Change in substantial holding 29 Apr 2026 10:04AM $0.125 $0.080 fallen by 36%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2026 8:22AM $0.140 $0.080 fallen by 42.86%
$18 Change in substantial holding 22 Apr 2026 2:47PM $0.160 $0.080 fallen by 50%

1 - 25 of 514 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.